Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Weller

Showing results (481-490 of 940) with videos related to

Pageof 94
Sort By:
European Journal of Cancer (Oxford, England : 1990)|December 24, 2014
Differentially regulated miRNAs as prognostic biomarkers in the blood of primary CNS lymphoma patientsPatrick Roth, Andreas Keller, Jörg D Hoheisel, et al.
Nature Reviews. Disease Primers|May 19, 2016
GliomaMichael Weller, Wolfgang Wick, Ken Aldape, et al.
Cell Reports|October 14, 2020
Neutrophils Obstructing Brain Capillaries Are a Major Cause of No-Reflow in Ischemic StrokeMohamad El Amki, Chaim Glück, Nadine Binder, et al.
Stem Cells and Development|November 6, 2009
Mouse mesenchymal stem cells suppress antigen-specific TH cell immunity independent of indoleamine 2,3-dioxygenase 1 (IDO1)Tobias V Lanz, Christiane A Opitz, Peggy P Ho, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2009
Long-term survival of patients with glioblastoma treated with radiotherapy and lomustine plus temozolomideMartin Glas, Caroline Happold, Johannes Rieger, et al.
The EMBO Journal|August 23, 2011
CAMTA1 is a novel tumour suppressor regulated by miR-9/9* in glioblastoma stem cellsDaniel Schraivogel, Lasse Weinmann, Dagmar Beier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2013
Long-term survival in primary glioblastoma with versus without isocitrate dehydrogenase mutationsChristian Hartmann, Bettina Hentschel, Matthias Simon, et al.
Plos One|October 7, 2015
Interferon-β Modulates the Innate Immune Response against Glioblastoma Initiating CellsFabian Wolpert, Caroline Happold, Guido Reifenberger, et al.
International Journal of Radiation Oncology, Biology, Physics|October 20, 2009
Chemoradiotherapy of newly diagnosed glioblastoma with intensified temozolomideMarkus Weiler, Christian Hartmann, Dorothee Wiewrodt, et al.
Journal of Sleep Research|July 3, 2018
In search of cerebrospinal fluid biomarkers of fatigue in multiple sclerosis: A proteomics studyPhilipp O Valko, Bernd Roschitzki, Wolfgang Faigle, et al.
Pageof 94

Showing results (481-490 of 940) with videos related to

Sort By:
Pageof 94
European Journal of Cancer (Oxford, England : 1990)|December 24, 2014
Differentially regulated miRNAs as prognostic biomarkers in the blood of primary CNS lymphoma patientsPatrick Roth, Andreas Keller, Jörg D Hoheisel, et al.
Nature Reviews. Disease Primers|May 19, 2016
GliomaMichael Weller, Wolfgang Wick, Ken Aldape, et al.
Cell Reports|October 14, 2020
Neutrophils Obstructing Brain Capillaries Are a Major Cause of No-Reflow in Ischemic StrokeMohamad El Amki, Chaim Glück, Nadine Binder, et al.
Stem Cells and Development|November 6, 2009
Mouse mesenchymal stem cells suppress antigen-specific TH cell immunity independent of indoleamine 2,3-dioxygenase 1 (IDO1)Tobias V Lanz, Christiane A Opitz, Peggy P Ho, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2009
Long-term survival of patients with glioblastoma treated with radiotherapy and lomustine plus temozolomideMartin Glas, Caroline Happold, Johannes Rieger, et al.
The EMBO Journal|August 23, 2011
CAMTA1 is a novel tumour suppressor regulated by miR-9/9* in glioblastoma stem cellsDaniel Schraivogel, Lasse Weinmann, Dagmar Beier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2013
Long-term survival in primary glioblastoma with versus without isocitrate dehydrogenase mutationsChristian Hartmann, Bettina Hentschel, Matthias Simon, et al.
Plos One|October 7, 2015
Interferon-β Modulates the Innate Immune Response against Glioblastoma Initiating CellsFabian Wolpert, Caroline Happold, Guido Reifenberger, et al.
International Journal of Radiation Oncology, Biology, Physics|October 20, 2009
Chemoradiotherapy of newly diagnosed glioblastoma with intensified temozolomideMarkus Weiler, Christian Hartmann, Dorothee Wiewrodt, et al.
Journal of Sleep Research|July 3, 2018
In search of cerebrospinal fluid biomarkers of fatigue in multiple sclerosis: A proteomics studyPhilipp O Valko, Bernd Roschitzki, Wolfgang Faigle, et al.
Pageof 94